Project Grant R03AG095418
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $440,000 to Northeastern University to conduct a qualitative study exploring the perspectives of racially and ethnically diverse homebound patients with advanced disease on advance care planning (ACP), intensive care services, hospice services, and related topics. The study will analyze audio recordings from a previous NIH-funded trial of a video-based ACP intervention delivered in home...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop an efficient, innovative, and resident-centered method to identify nursing home residents with unmet palliative care needs, with a focus on those with Alzheimer's disease and related dementias. The key objectives of the $145,043 grant, awarded on September 3, 2025, are to: (1) evaluate the content and face validity and iteratively refine a palliative care screening tool; (2)...
- This federal Project Grant award of $204,806 from the National Institute on Aging (CFDA 93.866 Aging Research) aims to adapt an evidence-based creative storytelling intervention called TimeSlips for older adults with mild cognitive impairment or mild Alzheimer's disease and related dementias in the primary care setting. The award will fund a pilot randomized trial of the adapted intervention, called TIME2CONNECT, to assess its potential to reduce loneliness in this population. The grant...
- This $2,307,536 federal Project Grant, awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), will leverage a natural experiment to examine the effects of integrated palliative care on health service outcomes and disparities in Parkinson's disease and Lewy body dementia. The primary awardee, The Trustees of the University of Pennsylvania, will: Examine patterns of palliative domain care and disparities across U.S. Parkinson's specialty centers; and Test the effects of a...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $639,740.00 to investigate the role of the CD38 enzyme in the development of chronic lung conditions following viral infections like COVID-19. The research aims to explore how targeting CD38 on CD8 tissue resident memory (TRM) cells could mitigate age-associated lung fibrosis after viral pneumonia. The award, effective December 15, 2024 through November 30, 2029, will support the lead researcher...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
- The National Institute on Aging (NIA) awarded a Project Grant totaling $173,730 to the University of Washington under the Aging Research federal grant program (CFDA 93.866) beginning on September 1, 2025. The goal of this Midcareer Investigator Award in Patient-Oriented Research is to enhance the ability of Dr. Claire Creutzfeldt to train, mentor, and support the career development of clinician-scientists focused on developing and testing interventions to improve the quality of life, quality...
- This federal Project Grant award titled "MISSED HOME HEALTH CARE IN OLDER ADULTS WITH DEMENTIA: IDENTIFYING DRIVERS, OUTCOMES, AND COSTS" is provided by the National Institute on Aging under the Aging Research program (CFDA 93.866). The $627,916 award will fund a 5-year research project at Kaiser Foundation Hospitals in Aurora, CO to identify key drivers and mitigators of missed home health care, examine the relationship between missed care and clinical outcomes/costs for older...
- The National Institute on Aging (NIA), under the federal Aging Research grant program (CFDA 93.866), awarded a $1,703,626 Project Grant to the University of North Dakota (UND) Division of Research & Economic Development. The grant, effective September 1, 2023 through August 31, 2026, will fund research to investigate the potential link between lung dysfunction and the progression of Alzheimer's disease (AD). Key objectives include: Characterizing the temporal changes in AD-related lung...
- This $3,687,278 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to optimize the validity of comparative effectiveness research in Alzheimer's disease and related dementias using large language models. The grant supports research at Brigham & Women's Hospital, a subsidiary of the Partners Healthcare System, to build novel large language models that can extract clinically relevant phenotypes from electronic health record data. This will...
This federal Project Grant award of $390,000 from the National Institute on Aging (part of the U.S. Department of Health and Human Services) under the Aging Research program (CFDA 93.866) aims to determine how serious illness communication differs between patients with chronic lung disease who have comorbid cognitive impairment without dementia compared to those with normal cognition. The research will involve two specific aims: 1) comparing self-report of serious illness conversations, completion of medical powers of attorney, and living wills between the two patient groups, and 2) other related analyses to understand communication differences. The award was made to the University of Colorado-Denver and has a period of performance from August 15, 2025 to July 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $390.0k | 8/6/25 |